UnitedHealth Group Incorporated $UNH Shares Purchased by Russell Investments Group Ltd.

Russell Investments Group Ltd. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,521,772 shares of the healthcare conglomerate’s stock after acquiring an additional 124,296 shares during the quarter. UnitedHealth Group comprises approximately 0.5% of Russell Investments Group Ltd.’s portfolio, making the stock its 23rd biggest holding. Russell Investments Group Ltd.’s holdings in UnitedHealth Group were worth $560,182,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of UNH. Eurizon Capital SGR S.p.A. grew its holdings in shares of UnitedHealth Group by 21.4% in the 3rd quarter. Eurizon Capital SGR S.p.A. now owns 811,167 shares of the healthcare conglomerate’s stock worth $299,279,000 after acquiring an additional 142,877 shares during the period. PBU The Pension Fund of Early Childhood & Youth Educators raised its holdings in UnitedHealth Group by 2.9% during the third quarter. PBU The Pension Fund of Early Childhood & Youth Educators now owns 84,834 shares of the healthcare conglomerate’s stock worth $31,141,000 after purchasing an additional 2,368 shares during the last quarter. Werba Rubin Papier Wealth Management raised its holdings in UnitedHealth Group by 6.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 1,691 shares of the healthcare conglomerate’s stock worth $621,000 after purchasing an additional 106 shares during the last quarter. Maryland State Retirement & Pension System purchased a new stake in UnitedHealth Group during the third quarter worth $20,248,000. Finally, Machina Capital S.A.S. acquired a new stake in UnitedHealth Group in the third quarter valued at $7,497,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group News Summary

Investors following UNH have been watching these news items:

  • Positive Sentiment: Analysts remain broadly optimistic, and one valuation assessment says UNH may still be below fair value after its past-year gains. The company’s focus on medical-cost management and pricing is central to whether it can sustain profit growth. Do Wall Street Analysts Like UnitedHealth Group Stock? UnitedHealth Group Stock Still Looks Below Fair Value
  • Neutral Sentiment: UnitedHealth added Madeline Bell, a children’s hospital CEO, to its board—the second board appointment since the company began its financial and operational turnaround. The appointment adds healthcare leadership experience, though its financial impact is uncertain. UnitedHealth Adds Children’s Hospital Executive to Board
  • Neutral Sentiment: A law firm invited shareholders to discuss potential claims involving company insiders. The release provides no substantiation or finding of wrongdoing, so it is not evidence of liability, though it may draw attention to legal and governance risks. Shareholder Rights Notice

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, October 13th. The Goldman Sachs Group boosted their price objective on shares of UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a research report on Friday, July 17th. Piper Sandler raised their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a report on Wednesday, October 14th. Cantor Fitzgerald lifted their target price on shares of UnitedHealth Group from $440.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Finally, Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $463.93.

Check Out Our Latest Stock Report on UNH

UnitedHealth Group Stock Performance

NYSE UNH opened at $405.45 on Friday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The business has a fifty day moving average of $391.23 and a 200-day moving average of $365.03. The stock has a market cap of $363.29 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 1.46 and a beta of 0.51.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The business’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter last year, the company earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio is 53.00%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.